Continuous renal replacement therapy for end-stage renal disease: The wearable artificial kidney (WAK)

Contributions to Nephrology

Volumn 149, Issue , 2005, Pages 325-333

  Gura, Victor ^a   Beizai, Masoud ^b   Ezon, Carlos ^b   Polaschegg, Hans Dietrich ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b National Quality Care Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; POTASSIUM; UREA;

ANIMAL; ARTICLE; ARTIFICIAL KIDNEY; BLOOD; CHRONIC KIDNEY FAILURE; EQUIPMENT DESIGN; EVALUATION; FEASIBILITY STUDY; RENAL REPLACEMENT THERAPY; SAFETY; SWINE;

ANIMALS; CREATININE; EQUIPMENT DESIGN; FEASIBILITY STUDIES; KIDNEY FAILURE, CHRONIC; KIDNEY, ARTIFICIAL; POTASSIUM; RENAL REPLACEMENT THERAPY; SAFETY; SWINE; UREA;

EID: 20544477737     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000085694     Document Type: Article

References (27)

1. Lockridge RS Jr: The direction of end-stage renal disease reimbursement in the United States. Semin Dial 2004;17:125-130.
2. Lockridge RS Jr, McKinney JK: Is HCFA's reimbursement policy controlling quality of care for end-stage renal disease patients? ASAIO J 2001;47:466-468.
3. Manns BJ, Johnson JA, Taub K, Mortis G, Ghali WA, Donaldson C: Dialysis adequacy and health related quality of life in hemodialysis patients. ASAIO J 2002;48:565-569.
4. Mapes DL, Lopes AA, Satayathum S, McCullough KP, Goodkin DA, Locatelli F, Fukuhara S, Young EW, Kurokawa K, Saito A, Bommer J, Wolfe RA, Held PJ, Port FK: Health-related quality of life as a predictor of mortality and hospitalization: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2003;64:339-349.
5. McFarlane PA, Bayoumi AM, Pierratos A, Redelmeier DA: The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis. Kidney Int 2003;64:1004-1011.
6. Mohr PE, Neumann PJ, Franco SJ, Marainen J, Lockridge R, Ting G: The case for daily dialysis: Its impact on costs and quality of life. Am J Kidney Dis 2001;37:777-789.
7. Patel SS, Shah VS, Peterson RA, Kimmel PL: Psychosocial variables, quality of life, and religious beliefs in ESRD patients treated with hemodialysis. Am J Kidney Dis 2002;40:1013-1022.
8. Marantz LB, Giorgianni MG, inventors: Urease in insoluble form for converting urea present in liquid. US patent 3989622, 11/2/1976.
9. Beltz AD, inventor: Wearable, portable, light-weight artificial kidney. US patent 5284470, 2/8/1994.
10. Bonomini V, Roggeri G, inventors: Hemodialysis and/or ultrafiltration apparatus. US patent 4269708, 5/26/1981.
11. Henne W, inventor: Artificial kidney. US patent 4212738, 7/15/1980.
12. Horiuchi T: [Wearable artificial kidney, portable artificial kidney and implantable artificial kidney]. Nippon Rinsho 2004;62(suppl 5):182-188.
13. Kolff WJ, Jacobsen S, Stephen RL, Rose D: Towards a wearable artificial kidney. Kidney Int 1976;(suppl 7):S300-S304.
14. Mineshima M: [Artificial kidney therapy in next generation]. Nippon Rinsho 2004; 62(suppl 6): 606-609.
15. Roberts M, Lee DB-N, inventors: Wearable peritoneum-based system for continuous renal function replacement and other biomedical applications. US patent 5944684, 8/31/1999.
16. Scott RD, inventor: Wearable, continuously internally operable and externally regenerable dialysis device. US patent 4765907, 8/23/1988.
17. Murisasco A, Reynier JP, Ragon A, Boobes Y, Baz M, Durand C, Bertocchio P, Agenet C, el Mehdi M: Continuous arterio-venous hemofiltration in a wearable device to treat end-stage renal disease. Trans Am Soc Artif Intern Organs 1986;32:567-571.
18. Senoo S, Otsubo O, Watanabe T, Yamauchi J, Yamada Y, Inou T, Takai N, Takahashi H, Fukui H, Kawata Y: [The wearable artificial kidney: Development of a small blood pump]. Jinkou Zouki 1982;11:48.
19. Tada Y, Horiuchi T, Ohta Y, Dohi T: A new approach for the filtrate regeneration system in the wearable artificial kidney. Artif Organs 1990;14:405-409.
20. Lockridge RS Jr: Daily dialysis and long-term outcomes - The Lynchburg Nephrology NHHD experience. Nephrol News Issues 1999;13:16, 19, 23-26.
21. Lockridge RS Jr, Spencer M, Craft V, Pipkin M, Campbell D, McPhatter L, Albert J, Anderson H, Jennings F, Barger T: Nocturnal home hemodialysis in North America. Adv Ren Replace Ther 2001;8:250-256.
22. Charra B, Chazot C, Jean G, Hurot JM, Vanel T, Terrat JC, Vovan C: Long 3 X 8 hr dialysis: A three-decade summary. J Nephrol 2003;16(suppl 7):S64-S69.
23. Charra B, Chazot C, Jean G, Laurent G: Long, slow dialysis. Miner Electrolyte Metab 1999;25:391-396.
24. Charra B, Terrat JC, Vanel T, Chazot C, Jean G, Hurot JM, Lorriaux C: Long thrice weekly hemodialysis: The Tassin experience. Int J Artif Organs 2004;27:265-283.
25. Gotch FA: The current place of area kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant 1998;13:10-14.
26. Murisasco A, Baz M, Boobes Y, Bertocchio P, el Mehdi M, Durand C, Reynier JP, Ragon A: A continuous hemofiltration system using sorbents for hemofiltrate regeneration. Clin Nephrol 1986;26(suppl 1):S53-S57.
27. Suri R, Depner TA, Blake PG, Heidenheim AP, Lindsay RM: Adequacy of quotidian hemodialysis. Am J Kidney Dis 2003;42(supp 1):S42-S48.